Jw Life Science Corp (234080) — Capital Reinvestment Ratio
Jw Life Science Corp (234080) has a Capital Reinvestment Ratio of 0.24x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩14.17 Billion) in capital expenditures (₩3.45 Billion). Check tangible equity quality of Jw Life Science Corp to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jw Life Science Corp Capital Reinvestment Ratio (2015–2025)
This chart tracks Jw Life Science Corp's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 234080 cash flow metrics.
Annual Capital Reinvestment Ratio for Jw Life Science Corp (2015–2025)
Year-by-year Capital Reinvestment Ratio for Jw Life Science Corp from 2015 to 2025. See Jw Life Science Corp (234080) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | ₩40.54 Billion | ₩13.43 Billion | ▲ +63.0% |
| 2024 | 0.20x | ₩50.69 Billion | ₩10.31 Billion | ▼ -7.6% |
| 2023 | 0.22x | ₩37.57 Billion | ₩8.27 Billion | ▼ -62.5% |
| 2022 | 0.59x | ₩14.13 Billion | ₩8.29 Billion | ▼ -6.7% |
| 2021 | 0.63x | ₩30.17 Billion | ₩18.98 Billion | ▲ +84.6% |
| 2020 | 0.34x | ₩46.75 Billion | ₩15.93 Billion | ▲ +2.2% |
| 2019 | 0.33x | ₩24.28 Billion | ₩8.09 Billion | ▲ +19.9% |
| 2018 | 0.28x | ₩36.13 Billion | ₩10.04 Billion | ▼ -30.1% |
| 2017 | 0.40x | ₩22.05 Billion | ₩8.77 Billion | ▼ -52.2% |
| 2016 | 0.83x | ₩16.08 Billion | ₩13.37 Billion | ▼ -7.0% |
| 2015 | 0.89x | ₩25.90 Billion | ₩23.14 Billion | — |